Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:06:27.821Z.
Calculation as of: 2026-10-06T17:06:27.821Z.
Quote observation: 2026-10-06T17:04:38.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 719625f658538d7511a1815ebd8f3969041d2dee7d9c9a78aa46ea1e1d2f6eab
EARNINGS YIELD
N/A
Market Cap
$303.90M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$300.57M
Earnings Yield
N/A
TTM Avg
4.04%
3Y Avg
4.04%
5Y Avg
4.04%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CapsoVision, Inc. (CV) | $324.02M | N/A | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $323.78M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $323.89M | N/A | N/A | N/A | N/A |
| Avita Medical Inc. (RCEL)vs › | $322.00M | N/A | N/A | N/A | N/A |
| Sanara MedTech Inc. (SMTI)vs › | $321.56M | N/A | 6.62% | 5.79% | 5.79% |
| Agenus Inc. (AGEN)vs › | $329.18M | 33.46% | 39.56% | 39.56% | 24.80% |
| C4 Therapeutics, Inc. (CCCC)vs › | $315.67M | N/A | N/A | N/A | N/A |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $303.90M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $300.57M | N/A | 4.04% | 4.04% | 4.04% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | N/A | 162.59% | 162.59% | 162.59% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
